Persistent or severe vomiting should be discussed with your prescribing provider to explore management options or timing adjustments
Glucagon-like receptor-1 agonists for obesity: weight loss outcomes, tolerability, side effects, and risks[J]
Type 2 diabetes is strongly associated with ED, with prevalence rates ranging from 35-75% depending on age, diabetes duration and glycaemic controlapproximately 2-3 times higher than in the general population
For experiments on mouse islets, each replicate (using different groups of islets) was regarded as a separate experiment and the number of mice used for each experiment is stated and, in each case, at least 4 mice were used
Emerging research is investigating whether lower maintenance doses might sustain weight loss while reducing cost and side effect burden, but this approach is not yet supported by randomized controlled trials and should only be undertaken with physician guidance